NEW YORK, April 20 (GenomeWeb News) - Strategic Diagnostics will provide Genomic Antibodies' antibodies to Berlex as part of an amendment of its supply agreement with the drug maker, the companies said today in a statement.

Genomic Antibodies' process will reduce the time it takes to produce antibodies for Berlex, Matthew Knight, Strategic Diagnostics president and CEO, said in the statement.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.